Gene · 2621
Papers3,604
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,121 to 1,140 of 3,604
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SKI-G-801, an AXL kinase inhibitor, blocks metastasis through inducing anti-tumor immune responses and potentiates anti-PD-1 therapy in mouse cancer models. | Clin Transl Immunology | 2022 | 35003748 | PubTator, text mining | PubMed |
| Role of synovial fibroblast subsets across synovial pathotypes in rheumatoid arthritis: a deconvolution analysis. | RMD Open | 2022 | 34987094 | PubTator, text mining | PubMed |
| Long non-coding RNA GAS6-AS1 enhances breast cancer cell aggressiveness by functioning as a competing endogenous RNA of microRNA-215-5p to enhance SOX9 expression. | Exp Ther Med | 2022 | 34976151 | PubTator, text mining | PubMed |
| Soluble AXL is a novel blood marker for early detection of pancreatic ductal adenocarcinoma and differential diagnosis from chronic pancreatitis. | EBioMedicine | 2022 | 34973624 | PubTator, text mining | PubMed |
| Dynamic lipid turnover in photoreceptors and retinal pigment epithelium throughout life. | Prog Retin Eye Res | 2022 | 34971765 | PubTator, text mining | PubMed |
| Immunological Aspects of AXL/GAS-6 in the Context of Human Liver Regeneration. | Hepatol Commun | 2022 | 34951136 | PubTator, text mining | PubMed |
| Identification of novel proteins and mechanistic pathways associated with early-onset hypertension by deep proteomic mapping of resistance arteries. | J Biol Chem | 2022 | 34929167 | PubTator, text mining | PubMed |
| Unbiased immune profiling reveals a natural killer cell-peripheral nerve axis in fibromyalgia. | Pain | 2022 | 34913882 | PubTator, text mining | PubMed |
| Downregulated circular RNA hsa_circ_0005797 inhibits endometrial cancer by modulating microRNA-298/Catenin delta 1 signaling. | Bioengineered | 2022 | 34852711 | PubTator, text mining | PubMed |
| How Many Cell Types Are in the Kidney and What Do They Do? | Annu Rev Physiol | 2022 | 34843404 | PubTator, text mining | PubMed |
| Increased serum AXL is associated with radiographic knee osteoarthritis severity. | Int J Rheum Dis | 2022 | 34841689 | PubTator, text mining | PubMed |
| Bioinformatics analysis and experimental validation of differentially expressed genes in mouse articular chondrocytes treated with IL-1β using microarray data. | Exp Ther Med | 2022 | 34815758 | PubTator, text mining | PubMed |
| Disruption of β-Catenin-Dependent Wnt Signaling in Colon Cancer Cells Remodels the Microenvironment to Promote Tumor Invasion. | Mol Cancer Res | 2022 | 34799404 | PubTator, text mining | PubMed |
| Bemcentinib and Gilteritinib Inhibit Cell Growth and Impair the Endo-Lysosomal and Autophagy Systems in an AXL-Independent Manner. | Mol Cancer Res | 2022 | 34782372 | PubTator, text mining | PubMed |
| Efferocytosis in multisystem diseases (Review). | Mol Med Rep | 2022 | 34779503 | PubTator, text mining | PubMed |
| The role of tumor microenvironment and exosomes in dormancy and relapse. | Semin Cancer Biol | 2022 | 34757184 | PubTator, text mining | PubMed |
| Triterpenoid ursolic acid drives metabolic rewiring and epigenetic reprogramming in treatment/prevention of human prostate cancer. | Mol Carcinog | 2022 | 34727410 | PubTator, text mining | PubMed |
| GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication Stress. | Mol Cancer Res | 2022 | 34670865 | PubTator, text mining | PubMed |
| Prostate cancer dormancy and recurrence. | Cancer Lett | 2022 | 34624433 | PubTator, text mining | PubMed |
| Synovial single-cell heterogeneity, zonation and interactions: a patchwork of effectors in arthritis. | Rheumatology (Oxford) | 2022 | 34559213 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2621/papers?page=57